₹56.4 1.3 2.3%
Last Trade - 15/01/21
| Market Cap | £5.73m |
| Enterprise Value | £6.12m |
| Revenue | £1.28m |
| Position in Universe | 1973rd / 3046 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Mar | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 20.1 | 47.5 | 72.8 | 141.4 | 197.6 | 167.6 | +52.9% | ||||
| +4.5 | +60.2 | +37.9 | -56.3 | +5.5 | -30.9 | |||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Tejnaksh Healthcare Limited is an India-based company engaged in hospital activities. The Company offers healthcare services at 13 urology clinics, four urology hospitals and two dental super specialty clinics. The Company is operating one hospital at Dhule in Maharashtra. The Company's domains include Urology Hospitals, Nephrology Hospitals, Dental Clinics, Pathology Labs, Research and Development, Healthcare Equipment, Super Specialty Training Institutes, Simulation Institute and Stone Analysis Lab.
| Last Annual | March 31st, 2020 |
| Last Interim | September 30th, 2020 |
| Incorporated | February 18, 2008 |
| Public Since | October 27, 2015 |
| No. of Shareholders: | n/a |
| No. of Employees: | n/a |
| Sector | Healthcare |
| Industry | Healthcare Providers & Services |
| Index | |
| Exchange | Bombay Stock Exchange |
| Shares in Issue | 10,156,800 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | Sakri Road Dhule, MUMBAI, 424001, India |
| Web | http://tejnaksh.com/ |
| Phone | +91 2562 245995 |
| Contact | () |
| Auditors | P.D. DALAL & CO. |
As of 15/01/21, shares in Tejnaksh Healthcare are trading at ₹56.4, giving the company a market capitalisation of £5.73m. This share price information is delayed by 15 minutes.
Shares in Tejnaksh Healthcare are currently trading at ₹56.4 and the price has moved by 10.48% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Tejnaksh Healthcare price has moved by -6.79% over the past year.
There are no analysts currently covering Tejnaksh Healthcare.
Tejnaksh Healthcare is scheduled to issue upcoming financial results on the following dates:
Tejnaksh Healthcare does not currently pay a dividend.
Tejnaksh Healthcare does not currently pay a dividend.
Tejnaksh Healthcare does not currently pay a dividend.
To buy shares in Tejnaksh Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Tejnaksh Healthcare are currently trading at ₹56.4, giving the company a market capitalisation of £5.73m.
Here are the trading details for Tejnaksh Healthcare:
Based on an overall assessment of its quality, value and momentum, Tejnaksh Healthcare is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We were not able to load any forecast data for Tejnaksh Healthcare.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Tejnaksh Healthcare. Over the past six months, the relative strength of its shares against the market has been 0.9%. At the current price of ₹56.4, shares in Tejnaksh Healthcare are trading at 41.16% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Tejnaksh Healthcare PE ratio based on its reported earnings over the past 12 months is 49.75. The shares are currently trading at ₹56.4.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Tejnaksh Healthcare's management team is headed by:
Here are the top five shareholders of Tejnaksh Healthcare based on the size of their shareholding:
